Skip to main content
. 1998 Apr;42(4):885–888. doi: 10.1128/aac.42.4.885

TABLE 1.

Summary of levofloxacin pharmacokinetic parameter estimates for 10 healthy subjectsa

Levofloxacin dose and day Cmax (μg/ml) Tmax (h) AUCb (μg · h/ml) CL/F
Vss/F
t1/2 (h) Cumaxc (μg/ml) Aed (% dose) CLR
ml/min ml/min/kg Liters Liters/kg ml/min ml/min/kg
750 mg
 Day 1 (single dose) 7.13 ± 1.44 1.9 ± 0.7 82 ± 14 157 ± 28 2.06 ± 0.42 90 ± 14 1.17 ± 0.10 7.7 ± 1.3 403 ± 249 75 ± 6 118 ± 28 1.55 ± 0.36
 Day 10 (steady state) 8.60 ± 1.86 1.4 ± 0.5 91 ± 18 143 ± 29 1.88 ± 0.43 100 ± 16 1.29 ± 0.13 8.8 ± 1.5 822 ± 437 79 ± 5 116 ± 28 1.52 ± 0.39
1 g
 Day 14 (single dose) 8.85 ± 1.86 1.7 ± 0.4 111 ± 21 156 ± 34 2.05 ± 0.49 96 ± 22 1.24 ± 0.15 7.9 ± 1.5 667 ± 286 73 ± 8 113 ± 2.6 1.48 ± 0.36
 Day 23 (steady state) 11.8 ± 2.52 1.7 ± 0.6 118 ± 19 146 ± 29 1.91 ± 0.40 105 ± 27 1.36 ± 0.17 8.9 ± 2.5 992 ± 377 71 ± 5 106 ± 23 1.38 ± 0.31
a

Values are means ± SD. 

b

The AUC is the AUC0–∞ for single doses (days 1 and 14) and the AUC0–24 at steady state (days 10 and 23). 

c

Cumax, peak urinary levofloxacin concentration. 

d

Ae, cumulative amount of levofloxacin recovered from urine from 0 to 72 h for single doses (days 1 and 14) and from 0 to 24 h at steady state (days 10 and 23).